By using the most advanced genetic analysis tools and applications, Genoox translates complex genetic data into clear and actionable clinical answers. Genoox partnered with Liquid to design “Franklin” - their innovative AI-leveraging computed classification engine.
Next-generation sequencing (NGS) is a new technology used for sequencing and variant detection. Genoox removes the final barrier to widespread adoption of clinical NGS, enabling personalised medicine for mainstream patients.
AI powered classification
Genoox’ Franklin employs an advanced AI classification tool to automatically identify and rank pathogenic variants according to ACMG guidelines: Pathogenic, Likely Pathogenic, Uncertain, Likely Benign and Benign
The basic functionality Franklin offers is the variant search - easily enter the variant you want to investigate, and it will open the variant interpretation hub where you can find the variant classification and all annotated data collected by Franklin.
Twenty Huge professionals embedded within the Telus team to craft a new design and development model.
Franklin community members are encouraged to share their insights and Expand Genomics Clinical Knowledge. As part of the variant interpretation process, the user can select to link a publication, post a note, or share the classification.
Automated and customizable
Genoox gene-level decision support for physicians and collaborators, enabling integration for third-party downstream integration.
By thinking holistically about the digital ecosystem, it’s easier and less expensive to push innovative ideas to market.